In this study, we examine whether miR-198-mediated downregulation of VCP may contribute to autophagy disruption and identify a potential mechanism through which miR-198 administration can sensitize pancreatic cancer cells to gemcitabine treatment. This evidence concerns the gene VCP and familial pancreatic carcinoma.